Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

White matter disease: Early treatment of inflammatory demyelinating disease.
Fingolimod therapy for multiple sclerosis.
How scientists fool themselves - and how they can stop.
Pregnancy Does Not Prove Neuroprotective for Women with MS Who Stop Taking Natalizumab
Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series.
Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.
Pediatric familial neuromyelitis optica in two sisters with long term follow-up.
Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic.
The role of KIR2DS1 in multiple sclerosis: KIR in Portuguese MS patients.
Autoimmune priming tissue attack and chronic inflammation - The three stages of rheumatoid arthritis.
Adaptive personalized training games for individual and collaborative rehabilitation of people with multiple sclerosis.
The oncoprotein and transcriptional regulator bcl-3 governs plasticity and pathogenicity of autoimmune T cells.
Multi-parametric representation of voxel-based quantitative magnetic resonance imaging.
Brain atrophy in natalizumab-treated patients: A 3-year follow-up.
The human oligodendrocyte proteome.
Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment.
Optic neuritis: Experience from a south Indian demyelinating disease registry.
Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints.
Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?
Laparoscopic appendectomy in a pediatric patient with type 1 Charcot-Marie-Tooth disease.

Pages